Re: Pre-Exposure Prophylaxis for Mitigating Risk of HIV Transmission During HIV Cure-Related Clinical Trials With a Treatment Interruption

Morenike Oluwatoyin Folayan^{1

2}, Bridget Haire³, Veronica Noseda⁴

Affiliations

¹ Department of Child Dental Health, Obafemi Awolowo University, Ile-Ife, Nigeria.
² New HIV Vaccine and Microbicide Advocacy Society, Lagos, Nigeria.
³ Kirby Institute, University of New South Wales, Sydney, Australia.
⁴ Vaccine Advocacy Resource Group, Durban, South Africa.

Comment

Morenike Oluwatoyin Folayan et al. J Infect Dis. 2019.

. 2019 Aug 30;220(7):1231-1233.

doi: 10.1093/infdis/jiz263.

Morenike Oluwatoyin Folayan^{1

2}, Bridget Haire³, Veronica Noseda⁴

¹ Department of Child Dental Health, Obafemi Awolowo University, Ile-Ife, Nigeria.
² New HIV Vaccine and Microbicide Advocacy Society, Lagos, Nigeria.
³ Kirby Institute, University of New South Wales, Sydney, Australia.
⁴ Vaccine Advocacy Resource Group, Durban, South Africa.

No abstract available

Comment in

Reply to Dee, and Johnson and Folayan.
Lelièvre JD. Lelièvre JD. J Infect Dis. 2019 Aug 30;220(7):1234. doi: 10.1093/infdis/jiz265. J Infect Dis. 2019. PMID: 31505664 No abstract available.

Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate.
Lelièvre JD, Hocqueloux L. Lelièvre JD, et al. J Infect Dis. 2019 Jul 2;220(220 Suppl 1):S5-S6. doi: 10.1093/infdis/jiz012. J Infect Dis. 2019. PMID: 30779842 Free PMC article.
Preexposure Prophylaxis for Mitigating Risk of HIV Transmission During HIV Cure-Related Clinical Trials With a Treatment Interruption.
Lelièvre JD. Lelièvre JD. J Infect Dis. 2019 Jul 2;220(220 Suppl 1):S16-S18. doi: 10.1093/infdis/jiz036. J Infect Dis. 2019. PMID: 30860581 Free PMC article.